维普中文期刊产品整合服务
27篇 您的检索式:作者名="BIDARD F"
    题名 作者 年代 出处 被引量
1Disseminated tumor cells of breast cancer patients:a strong prognostic factor for distant and local relapse显示文摘Bidard F C Vmcent-Salomon A Gomme S 2008Clin Cancer Res2008,14,11:1
2Contemporary issues and the potential uses of capecitabine in metastatic breast cancer显示文摘Lee P B Bidard F C Pierga J Y 2009Cancer Treatment Reviews2009,35,7:1
3Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells显示文摘Bidard F C Vincent-Salomon A Sigal-Zafrani B 2008Ann Oncol2008,19,3:1
4Circulating tumor cells 显示文摘Bidard F Ligthart ST Bachelot T 2012Annals of Oncology2012,22,2:1
5p53 status and efficacy of primary anthracyclines/alkylating agent based regimen according to breast cancer molecular classes显示文摘Bidard F C Matthieu M C Chollet P 2008Ann Oncol2008,19,7:1
6Assessment of circu- lating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study显示文摘Bidard F C Hajage D Bachelot T 2012Breast Cancer Res2012,14,1:1
7Efficacy of FOLFIRI-3(irinotecan Dl,D3 combined with LV5-FU)or other irinotecan-based regimens in oxaliplatin-pretreated metastatic colorectal cancer in the GERCOR OPTIMOX1 study显示文摘BIDARD F C TOURNIGAND Ct ANDRE T 2009Ann Oncol2009,20,6:1
8Does triple-negative phenotype accurately identify basal-like tumour An immunohistochemical analysis based on 143 triple-negative breast cancers显示文摘Bidard F C Conforti R Boulet T 2007Annals of oncology2007,18,7:1
9Efficacy of FOLFIRI-3 (irinotecan D1, D3 combined with LV5-FU) or other irinotecan-based regimens in oxaliplatin-pretreated metastatic colorectal cancer in the GERCOR OPTIMOX1 study显示文摘Bidard FC Tournigand C André T Mabro M Figer A Cervantes A Lledo G Bengrine-Lefevre L Maindrault-Goebel F Louvet C de Gramont A 2009Ann Oncol2009,20,6:1
10Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer显示文摘Bidard F C Mathiot C Delaloge S 2010Ann Oncol2010,21,4:1
11Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast canc- er in a phase II randomized trial 显示文摘Pierga J Y Bidard F C Mathiot C 2008Clin Cancer Res2008,14,21:1
12Characterization of Schizosaccharomyces pombe malate permease by expression in Saccharomyces cerev/s/ae显示文摘CAMARASA C BIDARD F BONY M 2001Applied and Environmental Microbiology2001,67,41:1
13p53 status and efficacy of primary anthracyclines/alkylating agent-based regimen according to breast cancer molecular classes显示文摘Bidard F C Matthieu M C Chollet P 2008Ann Oncol2008,19,7:1
14Efficacy of FOLFIRI-3(irinotecan D1,D3 combined with LV5-FU)or other irinotecan-based regimens in oxaliplatin-pretreated metastatic colorectal cancer in the GERCOR OPTIMOX1study显示文摘Bidard F C Tournigand C AndréT 2009Ann Oncol2009,20,6:1
15A 'class action' against the microenvironment:do cancer cells cooperate in metastasis?显示文摘BIDARD F C PIERGA J Y VINCENT-SALOMON A 2008Cancer Metastasis Rev2008,27,1:1
16A 'class action' a- gainst the mi ent: do cancer cells cooperate in metasta sis显示文摘Bidard F C Pierga J Y Vincent-Salomon A 2008Cancer Mestasis Rev2008,27,1:1
17The Saccharomyces cerevisiae FLO1 flocculation gene encodes a cell surface protein显示文摘BIDARD F BONY M BLONDIN B 1995Yeast1995,11,:1
18Circulating tumor cells in lo- cally advanced pancreatic adenocarcinoma: The ancillary CirCe 07 study to the LAP 07 trial 显示文摘Bidard FC Huguet F Louvet C 2013Annals of Oncology2013,24,8:1
19Circulating tumor cells in locally advanced pancreatic adenocarcinoma: The ancil- lary CirCe07study to the LAP 07 trial 显示文摘BIDARD FC HUGUET F LOUVET C 2013Ann Oncol2013,24,8:1
20Circulating tumor cells in locally advanced pancreatic adenocarcinoma : the an cil- lary CirCe 07 study to the LAP 07 trial 显示文摘BIDARD FC HUGUET F LOUVET C 2013Ann Oncol2013,24,8:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费